{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:40:14Z","timestamp":1759124414157,"version":"3.44.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017008","name":"Cancer Research UK Manchester Centre","doi-asserted-by":"publisher","award":["C147\/A18083","C147\/A25254","C19221\/A22746"],"award-info":[{"award-number":["C147\/A18083","C147\/A25254","C19221\/A22746"]}],"id":[{"id":"10.13039\/501100017008","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.radonc.2022.09.009","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T21:41:40Z","timestamp":1663623700000},"page":"53-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Bayesian methods provide a practical real-world evidence framework for evaluating the impact of changes in radiotherapy"],"prefix":"10.1016","volume":"176","author":[{"given":"Isabella","family":"Fornacon-Wood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitesh","family":"Mistry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinne","family":"Johnson-Hart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinne","family":"Faivre-Finn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James P.B.","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gareth J.","family":"Price","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2022.09.009_b0005","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0360-3016(00)01401-2","article-title":"Estimating the need for radiotherapy for lung cancer: An evidence-based, epidemiologic approach","volume":"49","author":"Tyldesley","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.09.009_b0010","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20190524","article-title":"The evolving role of radiotherapy in non-small cell lung cancer","volume":"92","author":"Brown","year":"2019","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2022.09.009_b0015","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"Bradley","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2022.09.009_b0020","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2022.09.009_b0025","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1016\/S1470-2045(11)70379-5","article-title":"Evaluation of novel radiotherapy technologies: What evidence is needed to assess their clinical and cost effectiveness, and how should we get it?","volume":"13","author":"Van Loon","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2022.09.009_b0030","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.clon.2012.06.003","article-title":"Methodological Considerations in the Evaluation of Radiotherapy Technologies","volume":"24","author":"Burnet","year":"2012","journal-title":"Clin Oncol"},{"key":"10.1016\/j.radonc.2022.09.009_b0035","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1191\/1740774504cn042oa","article-title":"Statistical evaluation of learning curve effects in surgical trials","volume":"1","author":"Cook","year":"2004","journal-title":"Clin Trials"},{"key":"10.1016\/j.radonc.2022.09.009_b0040","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/1472-6963-11-178","article-title":"Factors affecting the implementation of complex and evolving technologies: Multiple case study of intensity-modulated radiation therapy (IMRT) in Ontario, Canada","volume":"11","author":"Bak","year":"2011","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.radonc.2022.09.009_b0045","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.3109\/0284186X.2015.1067719","article-title":"The evaluation of innovation in radiation oncology - What can we do and what should we do?","volume":"54","author":"Pignol","year":"2015","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.radonc.2022.09.009_b0050","unstructured":"National Institute for Health and Care Excellence. NICE Real-World Evidence Framework.; 2022."},{"key":"10.1016\/j.radonc.2022.09.009_b0055","unstructured":"Food and Drug Administration. Framework for FDA\u2019s Real World Evidence Program.; 2018."},{"key":"10.1016\/j.radonc.2022.09.009_b0060","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ijrobp.2018.05.052","article-title":"Residual Setup Errors Towards the Heart After Image Guidance Linked With Poorer Survival in Lung Cancer Patients: Do We Need Stricter IGRT Protocols?","volume":"102","author":"Johnson-Hart","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.09.009_b0065","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.ijrobp.2021.12.011","article-title":"Understanding the Differences Between Bayesian and Frequentist Statistics","volume":"112","author":"Fornacon-Wood","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.09.009_b0070","unstructured":"Characteristics of the Weibull Distribution. https:\/\/www.weibull.com\/hotwire\/issue14\/relbasics14.htm. Accessed January 19, 2021."},{"key":"10.1016\/j.radonc.2022.09.009_b0075","first-page":"981","article-title":"Comparison of cox regression and parametric models: Application for assessment of survival of pediatric cases of acute leukemia in southern Iran","volume":"18","author":"Teshnizi","year":"2017","journal-title":"Asian Pacific J Cancer Prev"},{"key":"10.1016\/j.radonc.2022.09.009_b0080","unstructured":"Igl W. Calculation of Hazard Ratios of Parametric Survival Models in R - A Tutorial.; 2018."},{"key":"10.1016\/j.radonc.2022.09.009_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v080.i01","article-title":"brms: An R package for Bayesian multilevel models using Stan","volume":"80","author":"B\u00fcrkner","year":"2017","journal-title":"J Stat Softw"},{"key":"10.1016\/j.radonc.2022.09.009_b0090","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. 2020."},{"key":"10.1016\/j.radonc.2022.09.009_b0095","doi-asserted-by":"crossref","first-page":"395","DOI":"10.32614\/RJ-2018-017","article-title":"Advanced Bayesian multilevel modeling with the R package brms","volume":"10","author":"B\u00fcrkner","year":"2018","journal-title":"R J"},{"key":"10.1016\/j.radonc.2022.09.009_b0100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.radonc.2020.04.008","article-title":"Impact of small residual setup errors after image guidance on heart dose and survival in non-small cell lung cancer treated with curative-intent radiotherapy","volume":"152","author":"Johnson-Hart","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.09.009_b0105","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1093\/fampra\/17.suppl_1.S11","article-title":"Experimental and quasi-experimental designs for evaluating guideline implementation strategies","volume":"17","author":"Grimshaw","year":"2000","journal-title":"Fam Pract"},{"key":"10.1016\/j.radonc.2022.09.009_b0110","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.radonc.2022.05.002","article-title":"Causal relation between heart irradiation and survival of lung cancer patients after radiotherapy","volume":"172","author":"Brink","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.09.009_b0115","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1164\/rccm.202006-2381CP","article-title":"Using bayesian methods to augment the interpretation of critical care trials. an overview of theory and example reanalysis of the alveolar recruitment for acute respiratory distress syndrome trial","volume":"203","author":"Zampieri","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.radonc.2022.09.009_b0120","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.3389\/fpsyg.2020.608045","article-title":"The Importance of Prior Sensitivity Analysis in Bayesian Statistics: Demonstrations Using an Interactive Shiny App","volume":"11","author":"Depaoli","year":"2020","journal-title":"Front Psychol"},{"key":"10.1016\/j.radonc.2022.09.009_b0125","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/bioinformatics\/btv631","article-title":"Bayesian inference with historical data-based informative priors improves detection of differentially expressed genes","volume":"32","author":"Li","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.radonc.2022.09.009_b0130","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1177\/0962280217694506","article-title":"Including historical data in the analysis of clinical trials: Is it worth the effort?","volume":"27","author":"van Rosmalen","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.radonc.2022.09.009_b0135","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12874-019-0739-3","article-title":"Using Bayesian adaptive designs to improve phase III trials: A respiratory care example","volume":"19","author":"Ryan","year":"2019","journal-title":"BMC Med Res Method"},{"key":"10.1016\/j.radonc.2022.09.009_b0140","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1053\/j.seminhematol.2008.04.003","article-title":"A Dirty Dozen: Twelve P-Value Misconceptions","volume":"45","author":"Goodman","year":"2008","journal-title":"Semin Hematol"},{"key":"10.1016\/j.radonc.2022.09.009_b0145","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10654-016-0149-3","article-title":"Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations","volume":"31","author":"Greenland","year":"2016","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.radonc.2022.09.009_b0150","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/bmj.311.7003.485","article-title":"Absence of evidence is not evidence of absence","volume":"311","author":"Altman","year":"1995","journal-title":"BMJ"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814022042761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814022042761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:22:49Z","timestamp":1759123369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814022042761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":30,"alternative-id":["S0167814022042761"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2022.09.009","relation":{},"ISSN":["0167-8140"],"issn-type":[{"type":"print","value":"0167-8140"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bayesian methods provide a practical real-world evidence framework for evaluating the impact of changes in radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2022.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}